Objective: Clinical trials in patients with stable angina show that drugs that partially inhibit myocardial fatty acid oxidation reduce the symptoms of demand-induced ischemia, presumably by reducing lactate production and improving regional systolic function. We tested the hypothesis that partial inhibition of fatty acid oxidation with oxfenicine (a carnitine palmitoyl transferase-I inhibitor) reduces lactate production and increases regional myocardial power during demand-induced ischemia. Methods: Demand-induced ischemia was produced in anesthetized open-chest swine by reducing flow by 20% in the left anterior descending coronary artery and increasing heart intracoronary infusion of [U-C] glucose and [9,10-H] oleate, and hearts were treated with oxfenicine (2 mmol l ; n57) or vehicle (n57). Regional anterior wall power was assessed from the left ventricular pressure-anterior free wall segment length loops. Results:
P artial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia a , b a a 1 . Introduction reductions in flow that result in lactate production [17, 18, 22, 26, 35] . Fatty acid oxidation strongly inhibits the Coronary artery disease patients commonly have demitochondrial enzyme pyruvate dehydrogenase and oxidacreased coronary flow reserve, thus, in response to stress tion of the glycolytic intermediate pyruvate. Pharmacoand a greater demand for oxygen, they fail to sufficiently logical inhibition of fatty acid oxidation increases pyruvate increase coronary flow and myocardial oxygen consumpoxidation and the uptake and oxidation of glucose and tion (MV O ) resulting in 'demand-induced' ischemia lactate under aerobic conditions in humans and animals 2 [26, 32] . The normal healthy heart gets approximately 2 / 3 [16, 24, 34] . It has been proposed that agents that partially of its energy from fatty acid oxidation, even during partial inhibit myocardial fatty acid oxidation are efficacious during demand-induced ischemia in stable angina patients because they reduce lactate production, prevent intracellu-lar metabolic acidosis resulting in improved regional masked down with isoflurane, intubated, ventilated, and systolic function. This mechanism, however, has never anesthesia was maintained with isoflurane. The heart was been demonstrated.
exposed via a midline sternotomy [27] , the animal heparinWe have recently developed a model of demand-induced ized and a 20% triglyceride emulsion was infused to ischemia in pigs, where ischemia is the result of flow increase plasma free fatty acids to approximately 0.6 mmol 21 restriction and dobutamine stimulation of heart rate and l [31] . Left anterior descending coronary artery (LAD) contractility, with no change in MV O [5] . Despite no blood flow was controlled through an extra-corporeal 2 change in MV O , there was a switch from lactate uptake to perfusion circuit via a roller pump with blood taken from 2 production, glycogen depletion and increased glucose the femoral artery, as previously described in detail uptake, but no change in anterior wall power or the [20, 27, 31] . Arterial blood samples were obtained from a 21 anterior wall energy efficiency index. Furthermore, there constant flow (10 ml min ) withdrawal loop from the was no change in fatty acid uptake, yet exogenous fatty LAD perfusion circuit so that blood sampling would not acid oxidation was decreased. Thus, demand-induced disturb coronary artery blood flow. A dual-transducer ischemia stimulated non-oxidative glycolysis and lactate catheter was used to assess left ventricular (LV) pressure. production, but did not affect fatty acid uptake or anterior A cannula was placed in the anterior interventricular vein wall power for a given MV O .
to collect venous blood samples from the perfusion zone of 2 Traditional therapies for myocardial ischemia act by the LAD. Regional segment length was measured at improving oxygen delivery to the ischemic cardiac muscle approximately midwall depth in the LAD bed using or by decreasing the requirement of the myocardium for sonomicrometry as previously described [11, 20] . This oxygen by decreasing the heart rate, blood pressure or the preparation allowed us to subject the LAD perfusion bed to inotropic state of the muscle. These therapies lessen the demand-induced ischemia by infusing dobutamine while degree of ischemia by better matching the delivery of decreasing LAD flow by 20%. During demand-induced oxygen to the amount of work the myocardium performs ischemia, anterior wall contractile dysfunction was as- [32] . An alternative approach to these therapies is pharmasessed from the decrease in the LV pressure-segment cological optimization of cardiac energy metabolism. The length loop area from normal conditions to demand-inadvantage of these therapies over traditional therapies is duced ischemia. The right main and circumflex coronary that they would increase the mechanical efficiency of the artery blood flows were not restricted [10, 11] . ischemic region without an increase in myocardial blood flow or MV O , and without suppressing cardiac contractili-2 .2. Experimental protocol 2 ty. There is no direct evidence, however, that these metabolic agents reduce lactate production or improve Following completion of the instrumentation, a continu- 14 21 regional myocardial contractile function or mechanical ous infusion of [U-C] glucose (0.2 mCi min ) and 3 21 efficiency during demand-induced ischemia. Therefore, we [9,10-H] oleate (0.2 mCi min ) was introduced into the tested the hypothesis that partial inhibition of fatty acid proximal end of the coronary perfusion line at a rate of 0.1 21 oxidation with oxfenicine (a carnitine palmitoyl transml min . The radioactivity dose was greatly reduced, as ferase-I (CPT-I) inhibitor) would reduce the production of was the extent of secondary labeling, by infusing tracer lactate and improve regional myocardial contractile funcdirectly into the coronary perfusion circuit. After 30 min of 21 tion during demand-induced ischemia. tracer infusion, vehicle or 2 mmol l oxfenicine were infused directly into the coronary perfusion circuit and arterial and interventricular venous samples were drawn 10 2 . Methods min apart (40, 50 and 60 min after tracer infusion). Sixty minutes after initiating the tracer infusion, demand-induced Experiments were performed on 14 domestic pigs ischemia was initiated with an infusion of dobutamine (15 21 21 (vehicle, n57 mean weight 40.560.9 kg; oxfenicine, n57, mg kg min ) to increase myocardial oxygen demand mean weight 39.361.5 kg). Experiments with vehicle and and by reducing LAD blood flow by 20% for a period of oxfenicine treated animals were performed concurrently, 20 min. Arterial and anterior interventricular venous blood however, the data from the vehicle group were published samples were then taken at 3, 6, 10 and 20 min of separately to present this novel model of experimental demand-induced ischemia. as described below. Heart rate, left ventricular pressure (LVP), peak positive and negative dP/dt, and segment 2 .1. Surgical preparation length were continuously recorded using a commercial on-line data acquisition system. Small myocardial biopsies Overnight fasted animals were sedated with Telazol, (10-20 mg) were taken from the anterior LV free wall with a 14-gauge biopsy needle 5 min before initiating dilution of blood (|10%) derived from coronary arteries demand-induced ischemia, and at 8 and 18 min of demandother than the LAD by multiplying the measured values by induced ischemia, and were immediately freeze-clamped the concentration of green dye in venous plasma divided (3-5 s) on aluminum blocks pre-cooled in liquid nitrogen by the concentration in arterial plasma [29] . Myocardial 21 and stored at 280 8C for subsequent analysis. Tissue blood flow (ml min ) was measured from the calibrated lactate was assayed in these samples. After 20 min of pump flow of the coronary perfusion line. Myocardial demand-induced ischemia, two large (|3 g) punch biopsies oxygen consumption was calculated as the product of the were rapidly excised from the anterior and posterior LV arterial and venous oxygen concentration difference times free wall and freeze-clamped in large steel tongs prethe myocardial blood flow. cooled in liquid nitrogen. These samples were assayed for
The LV pressure (LVP)-segment length loop area was concentrations of tissue glycogen and triglycerides and for used as an index of external wall work (expressed as
21
PDH activities. mmHg mm beat ) of the anterior free wall. Anterior wall external power index was calculated as the LVP-segment length loop area times heart rate (expressed as mmHg mm 2 .3. Analytical methods C-glucose were deproteinized and analyzed for glucose ATP/ O consumed, plus the total lactate production (blood 2 and lactate using enzymatic spectrophotometric assays. were compared between normal conditions and demandlactic acid and trapping it in hyamine hydroxide. Plasma induced ischemia using two-way ANOVA. Lactate profree fatty acids were measured using a commercially duction, MV O and arterial and venous differences over 2 available enzymatic spectrophotometric kit. Tissue contime were analyzed using a two-way repeated measure centrations of ATP were measured using the ATP Biolumi-ANOVA, using a Student-Neuman-Keuls test for post-hoc nescent Assay Kit (Sigma Aldrich). Tissue lactate and comparisons. All values are reported as mean6S.E with a triglyceride concentrations were measured using enzymatic 0.05 level of significance. spectrophotometric methods. Tissue glycogen was assayed using the amyloglucosidase method.
Active and total PDH activity was determined using a 3 . Results newly developed radiochemical assay [33] . The assay is 14 based on the production of [1-C] acetyl-CoA from [2-3 .1. Hemodynamics 14 14 C] pyruvate, which is converted to [1-C] acetylcarnitine in the presence of excess L-carnitine and carnitine All hemodynamic variables are listed in Table 1 . In both 14 acetyltransferase. The positively charged product, [1-C] the vehicle and oxfenicine groups, heart rate (4868 and acetylcarnitine is then separated from the negatively 47610%), maximal positive dP/dt (8569 and 82614%) charged radiolabeled substrate by exclusion chromatogand maximal negative dP/dt (2969 and 3769%) were all raphy.
significantly increased during demand-induced ischemia (Table 1 and Fig. 1 ). MV O did not increase in the LAD 2 2 .4. Calculations perfusion bed in either group during the period of demandinduced ischemia (Table 1 and Fig. 1 ).
The net uptake (mmol min ) for glucose and free fatty acids were calculated as the product of the arterial and 3 . by the arterial specific radioactivity of glucose or free fatty groups, respectively. Arterial-venous concentration differ-21 acids (dpm mmol ) [36] . The interventricular venous ence (a-v difference) for free fatty acids was not different 14 3 concentrations of CO and H O were corrected for between the two groups, however, the a-v difference increased throughout demand-induced ischemia and was difference for glucose increased significantly (70 and 80 significantly greater at 80 min of demand-induced ischemia min) but was not different between the two groups. compared to normal conditions (Fig. 2) . Similarly, the a-v However, the uptake of lactate converted to production in both the vehicle and oxfenicine groups during demandinduced ischemia, but the a-v difference for lactate was significantly lower in the oxfenicine group (Fig. 2) . induced ischemia (63 min total protocol time), but was not During normal flow conditions there was net lactate significantly greater than normal conditions in the oxuptake, however, there was a dramatic switch to net lactate fenicine group until 6 min after the onset of demandproduction in both groups during demand-induced isinduced ischemia (or 66 min total protocol time). Furtherchemia (Table 2 ). The time course of lactate production more, the net lactate output integral (a measure of total (see Fig. 3, lower panel) indicates that a switch to lactate lactate production during demand-induced ischemia) was production occurred 3 min after the onset of demandgreater in the vehicle group compared to oxfenicine Values are means6S.E. Substrate uptakes were taken as the product of myocardial blood flow (ml min ) and arteriovenous differences for each substrate (average of 50 and 60 min during normal flow conditions, and 70 and 80 min during demand-induced ischemia). *P,0.05 demand-induced ischemia vs. normal conditions; †P,0.05 oxfenicine vs. vehicle compared to the vehicle group under both normal conditions (80624%) and during demand-induced ischemia (93650%) ( Table 2) . Furthermore, the percent of glucose taken up that was subsequently oxidized was greater in the oxfenicine group compared to the vehicle group under both normal conditions (2364 vs. 4169%, P,0.05) and during demand-induced ischemia (1963 vs. 2964%, P,0.05) (Fig. 4) . Greater rates of glucose oxidation during demandinduced were not accompanied by differences in either 21 total PDH activity (2.5260.11 vs. 2.7460.15 mmol min 21 gww ) or the percent of active PDH (7465 vs. 6969%) in the LAD bed between the two groups, suggesting that an increase in active PDH was not responsible for the increased glucose oxidation. wall (CFX bed) were not different between the two groups. The reduction in tissue glycogen content in the (1.160.25 vs. 0.6060.11 mmol; P,0.05). The switch ischemic LAD bed relative to the non-ischemic CFX bed from lactate uptake to lactate production was accompanied was significantly less in the oxfenicine group compared to by no change in MV O in either group. Demand-induced the vehicle group (4368% vs. 6666%, respectively) 2 ischemia caused a greater increase in myocardial tissue suggesting a glycogen sparing effect of oxfenicine during lactate content in the vehicle group compared to the demand-induced ischemia (Table 3) . Tissue ATP contents oxfenicine group (3716199 vs. 2126166%, respectively;
were not different between the vehicle and oxfenicine average of two time points during demand-induced isgroups under both normal conditions and during demandchemia compared to normal conditions) (Fig. 3, upper induced ischemia. panel).
Free fatty acid, glucose and lactate uptake and exogen-3 .3. Regional left ventricular wall work and power ous glucose and free fatty acid oxidation measurements are presented in Table 2 . Demand-induced ischemia resulted in Anterior wall work and power index were calculated significantly lower rates of fatty acid oxidation in both the from the LVP-segment length loop area using sonomicoxfenicine and vehicle groups despite no significant derometry [5] . Demand-induced ischemia resulted in a crease in tracer measured fatty acid uptake within each significant reduction in anterior wall work index (169635 21 21 group. However, the oxfenicine group had significantly vs. 109628 mmHg mm beat ; P,0.05) ( Table 1 ) and lower tracer-measured fatty acid uptake compared to the power index was unchanged (299647 vs. 311686 mmHg 21 21 vehicle group when the two conditions were combined mm s ) in the vehicle group (Fig. 5) . Oxfenicine (mean of normal conditions and demand-induced ischemia prevented a significant reduction in anterior wall work 21 21 21 combined; 7.6861.3 vs. 5.360.7 mmol min for the index (150640 vs. 13569 mmHg mm beat ) (Table 1 ) vehicle and oxfenicine groups, respectively, P,0.05).
and increased the anterior wall power index (3206105 vs.
Myocardial glucose uptake was significantly increased 3956107 mmHg mm s ) (Fig. 5) . during demand-induced ischemia in both groups and was
The estimated rate of ATP production was constant accompanied by significant increases in the rate of glucose between normal conditions and demand-induced ischemia oxidation in both groups. However, the rates of glucose in both the vehicle (11.561.2 and 12.461.3 mmol ATP 21 oxidation were significantly higher in the oxfenicine group s ) and oxfenicine groups (11.760.5 and 12.061.0 mmol as there was no increase in either total PDH activity or the percent of active PDH. While previous studies have shown improved cardiac function during low-flow ischemia / reperfusion [30] with partial inhibition of myocardial fatty acid oxidation, the present investigation was the first to demonstrate improved regional myocardial systolic function and mechanical efficiency during demand-induced ischemia.
In the present investigation we observed that partial inhibition of fatty acid oxidation with oxfenicine reduces lactate production and tissue lactate accumulation during demand-induced ischemia. In our swine model of demandinduced ischemia there is a dramatic switch from lactate uptake to production and marked lactate accumulation in the tissue, consistent with studies in coronary artery disease patients, which showed stimulation of lactate production when the heart was stressed by atrial pacing maintain Ca homeostasis and to utilize the energy released from ATP breakdown to perform contractile work [9, 23] . Furthermore, drugs such as trimetazidine [15] or 21 ATP s ). However, the switch to lactate production that ranolazine [21] , that decrease non-oxidative glycolysis by occurred during demand-induced ischemia, which conpartial inhibition of fatty acid oxidation, improve the 21 tributed 1.560.3 mmol ATP s or approximately symptoms of patients with exercise induced angina, most 11.961.4% of the total energy expenditure during demandlikely through increasing mitochondrial pyruvate oxidation induced ischemia, was significantly reduced in the oxresulting in a reduction of lactate efflux and / or accumula-
fenicine group to 0.860.2 mmol ATP s or 6.561.2% of tion. Our results show in a clinically relevant model of the total energy expenditure. Furthermore, as a result of an demand-induced ischemia that oxfenicine reduced this high increase in the anterior wall power index with no change in rate of non-oxidative glycolysis as demonstrated by less the estimated total ATP production, the anterior wall glycogen depletion and lactate accumulation and efflux, energy efficiency index was increased in the oxfenicine and greater glucose oxidation. group during demand-induced ischemia (Fig. 5) .
The consequence of the greater glucose oxidation and reduction in lactate production during demand-induced ischemia was a significant increase in external power and 4 . Discussion mechanical efficiency in the ischemic zone (Table 1 and Fig. 5 ). Traditional therapies for myocardial ischemia (e.g. The results of the present investigation show that partial beta blockers, calcium antagonists, or long acting nitrates), inhibition of fatty acid oxidation with the CPT-I inhibitor improve oxygen delivery to the ischemic cardiac muscle or oxfenicine reduced the rate of non-oxidative glycolysis and they reduce the oxygen requirement of the myocardium by improved regional mechanical function during demanddecreasing heart rate, blood pressure or inotropy [19, 32] . induced ischemia. During demand-induced ischemia, oxWhile these therapies effectively lessen the degree of fenicine resulted in less lactate production, glycogen ischemia by better matching the delivery of oxygen to the depletion and fatty acid uptake and oxidation, while amount of myocardial external power, they do not improve glucose oxidation, anterior wall power and myocardial myocardial mechanical efficiency. Although some studies energy efficiency were all enhanced. Furthermore, inhibiin the literature have demonstrated improvements in tion of fatty acid oxidation with oxfenicine, which has myocardial energetics with beta blocker therapy, these been shown to result in removal of fatty acid inhibition of studies were conducted in patients with idiopathic carpyruvate dehydrogenase [12, 13] , increased pyruvate oxidadiomyopathy [8] or left ventricular dysfunction [1] . To our tion during demand-induced ischemia. However, the inknowledge, this is the first study to demonstrate that partial creased pyruvate oxidation we observed in this study was inhibition of fatty acid oxidation improves myocardial not due to a removal of phosphorylation inhibition of PDH energy efficiency during demand-induced ischemia by 21 increasing myocardial contractile function at no additional Ca pump and myosin ATPase due to less lactate energy cost.
production and more optimal pH [9, 23] . It is important to note that the high rate of non-oxidative
In conclusion, the results of the present investigation glycolysis observed during demand-induced ischemia in show that partial inhibition of fatty acid oxidation with the the vehicle group accounts for only 11.961.4% of the total CPT-I inhibitor oxfenicine resulted in decreased lactate energy expenditure, but it clearly reflects a dramatic production, glycogen utilization and fatty acid uptake and disruption to normal myocardial metabolism as seen in the oxidation, and greater glucose oxidation, anterior wall marked lactate efflux and accumulation in the tissue.
power and myocardial energy efficiency. This is the first However, the contribution of non-oxidative glycolysis direct evidence that partial inhibition of myocardial fatty during demand-induced ischemia was significantly reduced acid oxidation will reduce lactate production and improve in the oxfenicine group to 6.561.2% of the total energy regional myocardial contractile function and mechanical expenditure. These results clearly demonstrate a reduction efficiency during demand-induced ischemia. Our findings in the contribution of non-oxidative glycolysis to the total suggest that this mechanism is responsible for the improveenergy expenditure of the myocardium during demandment in symptoms of exercise-induced ischemia in patients induced ischemia.
with chronic stable angina treated with partial inhibitors of During demand-induced ischemia, tracer measured fatty myocardial fatty acid oxidation. acid uptake and oxidation were both decreased and glucose oxidation was increased in the oxfenicine group. These changes in myocardial substrate use were accompanied by A cknowledgements enhanced anterior wall power index. Furthermore, this switch in myocardial substrate use occurred despite no This study was supported by the National Heart, Lung, activation of PDH, since neither total PDH activity or the and Blood Institute grant HL58653 to Dr W. Stanley and a percent active PDH were increased in the oxfenicine grant from Chugai Biopharmaceuticals Inc. group. Thus, during demand-induced ischemia, oxfenicine effectively enhanced glucose oxidation at the expense of fatty acid oxidation that resulted in improved myocardial R eferences contractile function. Pre-clinical and clinical studies have demonstrated that with myocardial ischemia or ischemia / human hearts [14] . Furthermore, oxfenicine attenuated cell ischemia [13] and increased the pacing time to angina in It has been suggested that improvement in cardiac greater theoretical ATP/ O ratio for glucose and lactate
